Global Prescription Dermatological Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Prescription Dermatological Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Anti-acne Drugs
1.2.3 Anti-aging Drugs
1.2.4 Dermatitis Drugs
1.2.5 Hair Loss Drugs
1.2.6 Psoriasis Drugs
1.2.7 Skin Cancer Drugs
1.2.8 Melasma Drugs
1.2.9 Seborrhea Drugs
1.3 Market Segment by Application
1.3.1 Global Prescription Dermatological Drugs Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Prescription Dermatological Drugs Market Size (2017-2028)
2.1.1 Global Prescription Dermatological Drugs Revenue (2017-2028)
2.1.2 Global Prescription Dermatological Drugs Sales (2017-2028)
2.2 Global Prescription Dermatological Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Prescription Dermatological Drugs Sales by Regions (2017-2022)
2.2.2 Global Prescription Dermatological Drugs Revenue by Regions (2017-2022)
2.3 Global Prescription Dermatological Drugs Market Size Forecast by Region
2.3.1 Global Prescription Dermatological Drugs Sales Forecast by Region (2023-2028)
2.3.2 Global Prescription Dermatological Drugs Revenue Forecast by Region (2023-2028)
2.4 Global Top Prescription Dermatological Drugs Regions (Countries) Ranking by Market Size
2.5 Prescription Dermatological Drugs Market Dynamics
2.5.1 Prescription Dermatological Drugs Market Trends
2.5.2 Prescription Dermatological Drugs Market Drivers
2.5.3 Prescription Dermatological Drugs Market Challenges
2.5.4 Prescription Dermatological Drugs Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Prescription Dermatological Drugs Manufacturers by Sales (2017-2022)
3.1.1 Global Prescription Dermatological Drugs Sales by Manufacturers (2017-2022)
3.1.2 Global Prescription Dermatological Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Prescription Dermatological Drugs Sales in 2021
3.2 Global Top Manufacturers Prescription Dermatological Drugs by Revenue
3.2.1 Global Prescription Dermatological Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Top Prescription Dermatological Drugs Manufacturers Covered: Ranking by Revenue
3.2.3 Global Prescription Dermatological Drugs Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Prescription Dermatological Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prescription Dermatological Drugs as of 2021)
3.4 Global Prescription Dermatological Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Prescription Dermatological Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Prescription Dermatological Drugs Market
3.7 Key Manufacturers Prescription Dermatological Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Prescription Dermatological Drugs Market Size by Type
4.1 Global Prescription Dermatological Drugs Historic Market Review by Type (2017-2022)
4.1.1 Global Prescription Dermatological Drugs Sales Market Share by Type (2017-2022)
4.1.2 Global Prescription Dermatological Drugs Revenue Market Share by Type (2017-2022)
4.1.3 Prescription Dermatological Drugs Price by Type (2017-2022)
4.2 Global Prescription Dermatological Drugs Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Prescription Dermatological Drugs Sales Forecast by Type (2023-2028)
4.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Type (2023-2028)
4.2.3 Prescription Dermatological Drugs Price Forecast by Type (2023-2028)
5 Global Prescription Dermatological Drugs Market Size by Application
5.1 Global Prescription Dermatological Drugs Historic Market Review by Application (2017-2022)
5.1.1 Global Prescription Dermatological Drugs Sales Market Share by Application (2017-2022)
5.1.2 Global Prescription Dermatological Drugs Revenue Market Share by Application (2017-2022)
5.1.3 Prescription Dermatological Drugs Price by Application (2017-2022)
5.2 Global Prescription Dermatological Drugs Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Prescription Dermatological Drugs Sales Forecast by Application (2023-2028)
5.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Application (2023-2028)
5.2.3 Prescription Dermatological Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Prescription Dermatological Drugs Sales Breakdown by Company
6.1.1 North America Prescription Dermatological Drugs Sales by Company (2017-2022)
6.1.2 North America Prescription Dermatological Drugs Revenue by Company (2017-2022)
6.2 North America Prescription Dermatological Drugs Market Size by Type
6.2.1 North America Prescription Dermatological Drugs Sales by Type (2017-2028)
6.2.2 North America Prescription Dermatological Drugs Revenue by Type (2017-2028)
6.3 North America Prescription Dermatological Drugs Market Size by Application
6.3.1 North America Prescription Dermatological Drugs Sales by Application (2017-2028)
6.3.2 North America Prescription Dermatological Drugs Revenue by Application (2017-2028)
6.4 North America Prescription Dermatological Drugs Market Size by Country
6.4.1 North America Prescription Dermatological Drugs Sales by Country (2017-2028)
6.4.2 North America Prescription Dermatological Drugs Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Prescription Dermatological Drugs Sales Breakdown by Company
7.1.1 Europe Prescription Dermatological Drugs Sales by Company (2017-2022)
7.1.2 Europe Prescription Dermatological Drugs Revenue by Company (2017-2022)
7.2 Europe Prescription Dermatological Drugs Market Size by Type
7.2.1 Europe Prescription Dermatological Drugs Sales by Type (2017-2028)
7.2.2 Europe Prescription Dermatological Drugs Revenue by Type (2017-2028)
7.3 Europe Prescription Dermatological Drugs Market Size by Application
7.3.1 Europe Prescription Dermatological Drugs Sales by Application (2017-2028)
7.3.2 Europe Prescription Dermatological Drugs Revenue by Application (2017-2028)
7.4 Europe Prescription Dermatological Drugs Market Size by Country
7.4.1 Europe Prescription Dermatological Drugs Sales by Country (2017-2028)
7.4.2 Europe Prescription Dermatological Drugs Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prescription Dermatological Drugs Sales Breakdown by Company
8.1.1 Asia Pacific Prescription Dermatological Drugs Sales by Company (2017-2022)
8.1.2 Asia Pacific Prescription Dermatological Drugs Revenue by Company (2017-2022)
8.2 Asia Pacific Prescription Dermatological Drugs Market Size by Type
8.2.1 Asia Pacific Prescription Dermatological Drugs Sales by Type (2017-2028)
8.2.2 Asia Pacific Prescription Dermatological Drugs Revenue by Type (2017-2028)
8.3 Asia Pacific Prescription Dermatological Drugs Market Size by Application
8.3.1 Asia Pacific Prescription Dermatological Drugs Sales by Application (2017-2028)
8.3.2 Asia Pacific Prescription Dermatological Drugs Revenue by Application (2017-2028)
8.4 Asia Pacific Prescription Dermatological Drugs Market Size by Region
8.4.1 Asia Pacific Prescription Dermatological Drugs Sales by Region
8.4.2 Asia Pacific Prescription Dermatological Drugs Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Prescription Dermatological Drugs Sales Breakdown by Company
9.1.1 Latin America Prescription Dermatological Drugs Sales by Company (2017-2022)
9.1.2 Latin America Prescription Dermatological Drugs Revenue by Company (2017-2022)
9.2 Latin America Prescription Dermatological Drugs Market Size by Type
9.2.1 Latin America Prescription Dermatological Drugs Sales by Type (2017-2028)
9.2.2 Latin America Prescription Dermatological Drugs Revenue by Type (2017-2028)
9.3 Latin America Prescription Dermatological Drugs Market Size by Application
9.3.1 Latin America Prescription Dermatological Drugs Sales by Application (2017-2028)
9.3.2 Latin America Prescription Dermatological Drugs Revenue by Application (2017-2028)
9.4 Latin America Prescription Dermatological Drugs Market Size by Country
9.4.1 Latin America Prescription Dermatological Drugs Sales by Country (2017-2028)
9.4.2 Latin America Prescription Dermatological Drugs Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prescription Dermatological Drugs Sales Breakdown by Company
10.1.1 Middle East and Africa Prescription Dermatological Drugs Sales by Company (2017-2022)
10.1.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Company (2017-2022)
10.2 Middle East and Africa Prescription Dermatological Drugs Market Size by Type
10.2.1 Middle East and Africa Prescription Dermatological Drugs Sales by Type (2017-2028)
10.2.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Type (2017-2028)
10.3 Middle East and Africa Prescription Dermatological Drugs Market Size by Application
10.3.1 Middle East and Africa Prescription Dermatological Drugs Sales by Application (2017-2028)
10.3.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Application (2017-2028)
10.4 Middle East and Africa Prescription Dermatological Drugs Market Size by Country
10.4.1 Middle East and Africa Prescription Dermatological Drugs Sales by Country (2017-2028)
10.4.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Prescription Dermatological Drugs Products and Services
11.1.5 Johnson & Johnson Prescription Dermatological Drugs SWOT Analysis
11.1.6 Johnson & Johnson Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Prescription Dermatological Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Merck Prescription Dermatological Drugs Products and Services
11.2.5 Merck Prescription Dermatological Drugs SWOT Analysis
11.2.6 Merck Recent Developments
11.3 LEO Pharma
11.3.1 LEO Pharma Corporation Information
11.3.2 LEO Pharma Overview
11.3.3 LEO Pharma Prescription Dermatological Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 LEO Pharma Prescription Dermatological Drugs Products and Services
11.3.5 LEO Pharma Prescription Dermatological Drugs SWOT Analysis
11.3.6 LEO Pharma Recent Developments
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Corporation Information
11.4.2 Mylan Pharmaceuticals Overview
11.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Products and Services
11.4.5 Mylan Pharmaceuticals Prescription Dermatological Drugs SWOT Analysis
11.4.6 Mylan Pharmaceuticals Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Prescription Dermatological Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Pfizer Prescription Dermatological Drugs Products and Services
11.5.5 Pfizer Prescription Dermatological Drugs SWOT Analysis
11.5.6 Pfizer Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Overview
11.6.3 Roche Prescription Dermatological Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Roche Prescription Dermatological Drugs Products and Services
11.6.5 Roche Prescription Dermatological Drugs SWOT Analysis
11.6.6 Roche Recent Developments
11.7 Allergan
11.7.1 Allergan Corporation Information
11.7.2 Allergan Overview
11.7.3 Allergan Prescription Dermatological Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Allergan Prescription Dermatological Drugs Products and Services
11.7.5 Allergan Prescription Dermatological Drugs SWOT Analysis
11.7.6 Allergan Recent Developments
11.8 Bausch Health
11.8.1 Bausch Health Corporation Information
11.8.2 Bausch Health Overview
11.8.3 Bausch Health Prescription Dermatological Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Bausch Health Prescription Dermatological Drugs Products and Services
11.8.5 Bausch Health Prescription Dermatological Drugs SWOT Analysis
11.8.6 Bausch Health Recent Developments
11.9 PharmaDerm Pharmaceuticals
11.9.1 PharmaDerm Pharmaceuticals Corporation Information
11.9.2 PharmaDerm Pharmaceuticals Overview
11.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Products and Services
11.9.5 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs SWOT Analysis
11.9.6 PharmaDerm Pharmaceuticals Recent Developments
11.10 Allergan Inamed Corporation
11.10.1 Allergan Inamed Corporation Corporation Information
11.10.2 Allergan Inamed Corporation Overview
11.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Products and Services
11.10.5 Allergan Inamed Corporation Prescription Dermatological Drugs SWOT Analysis
11.10.6 Allergan Inamed Corporation Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Prescription Dermatological Drugs Value Chain Analysis
12.2 Prescription Dermatological Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prescription Dermatological Drugs Production Mode & Process
12.4 Prescription Dermatological Drugs Sales and Marketing
12.4.1 Prescription Dermatological Drugs Sales Channels
12.4.2 Prescription Dermatological Drugs Distributors
12.5 Prescription Dermatological Drugs Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Prescription Dermatological Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Anti-acne Drugs
Table 3. Major Manufacturers of Anti-aging Drugs
Table 4. Major Manufacturers of Dermatitis Drugs
Table 5. Major Manufacturers of Hair Loss Drugs
Table 6. Major Manufacturers of Psoriasis Drugs
Table 7. Major Manufacturers of Skin Cancer Drugs
Table 8. Major Manufacturers of Melasma Drugs
Table 9. Major Manufacturers of Seborrhea Drugs
Table 10. Global Prescription Dermatological Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Prescription Dermatological Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 12. Global Prescription Dermatological Drugs Sales by Region (2017-2022) & (K Units)
Table 13. Global Prescription Dermatological Drugs Sales Market Share by Region (2017-2022)
Table 14. Global Prescription Dermatological Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Prescription Dermatological Drugs Revenue Market Share by Region (2017-2022)
Table 16. Global Prescription Dermatological Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 17. Global Prescription Dermatological Drugs Sales Market Share Forecast by Region (2023-2028)
Table 18. Global Prescription Dermatological Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 19. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 20. Top Prescription Dermatological Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 21. Prescription Dermatological Drugs Market Trends
Table 22. Prescription Dermatological Drugs Market Drivers
Table 23. Prescription Dermatological Drugs Market Challenges
Table 24. Prescription Dermatological Drugs Market Restraints
Table 25. Global Prescription Dermatological Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 26. Global Prescription Dermatological Drugs Sales Share by Manufacturers (2017-2022)
Table 27. Global Prescription Dermatological Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 28. Ranking of Global Top Prescription Dermatological Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 29. Prescription Dermatological Drugs Revenue Share by Manufacturers (2017-2022)
Table 30. Global Prescription Dermatological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prescription Dermatological Drugs as of 2021)
Table 32. Key Manufacturers Prescription Dermatological Drugs Average Selling Price (ASP) & (2017-2022) & (USD/Units)
Table 33. Key Manufacturers Prescription Dermatological Drugs Plants/Factories Distribution
Table 34. Key Manufacturers Prescription Dermatological Drugs Area Served
Table 35. Date of Key Manufacturers Enter into Prescription Dermatological Drugs Market
Table 36. Key Manufacturers Prescription Dermatological Drugs Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Prescription Dermatological Drugs Sales (K Units) by Type (2017-2022)
Table 39. Global Prescription Dermatological Drugs Sales Share by Type (2017-2022)
Table 40. Global Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Type (2017-2022)
Table 41. Global Prescription Dermatological Drugs Price (K Units) by Type (2017-2022)
Table 42. Global Prescription Dermatological Drugs Sales (K Units) by Type (2023-2028)
Table 43. Global Prescription Dermatological Drugs Sales Share by Type (2023-2028)
Table 44. Global Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Type (2023-2028)
Table 45. Global Prescription Dermatological Drugs Revenue Share by Type (2023-2028)
Table 46. Global Prescription Dermatological Drugs Price (K Units) by Type (2023-2028)
Table 47. Global Prescription Dermatological Drugs Sales (K Units) by Application (2017-2022)
Table 48. Global Prescription Dermatological Drugs Sales Share by Application (2017-2022)
Table 49. Global Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Application (2017-2022)
Table 50. Global Prescription Dermatological Drugs Price (K Units) by Application (2017-2022)
Table 51. Global Prescription Dermatological Drugs Sales (K Units) by Application (2023-2028)
Table 52. Global Prescription Dermatological Drugs Sales Share by Application (2023-2028)
Table 53. Global Prescription Dermatological Drugs Revenue (US$ Million) Market Share by Application (2023-2028)
Table 54. Global Prescription Dermatological Drugs Revenue Share by Application (2023-2028)
Table 55. Global Prescription Dermatological Drugs Price (K Units) by Application (2023-2028)
Table 56. North America Prescription Dermatological Drugs Sales by Company (2017-2022) & (K Units)
Table 57. North America Prescription Dermatological Drugs Sales Market Share by Company (2017-2022)
Table 58. North America Prescription Dermatological Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 59. North America Prescription Dermatological Drugs Revenue Market Share by Company (2017-2022)
Table 60. North America Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
Table 61. North America Prescription Dermatological Drugs Sales by Type (2023-2028) & (K Units)
Table 62. North America Prescription Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 63. North America Prescription Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 64. North America Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
Table 65. North America Prescription Dermatological Drugs Sales by Application (2023-2028) & (K Units)
Table 66. North America Prescription Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 67. North America Prescription Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 68. North America Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)
Table 69. North America Prescription Dermatological Drugs Sales by Country (2023-2028) & (K Units)
Table 70. North America Prescription Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 71. North America Prescription Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 72. Europe Prescription Dermatological Drugs Sales by Company (2017-2022) & (K Units)
Table 73. Europe Prescription Dermatological Drugs Sales Market Share by Company (2017-2022)
Table 74. Europe Prescription Dermatological Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 75. Europe Prescription Dermatological Drugs Revenue Market Share by Company (2017-2022)
Table 76. Europe Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
Table 77. Europe Prescription Dermatological Drugs Sales by Type (2023-2028) & (K Units)
Table 78. Europe Prescription Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 79. Europe Prescription Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 80. Europe Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Europe Prescription Dermatological Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Europe Prescription Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 83. Europe Prescription Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 84. Europe Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)
Table 85. Europe Prescription Dermatological Drugs Sales by Country (2023-2028) & (K Units)
Table 86. Europe Prescription Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 87. Europe Prescription Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 88. Asia Pacific Prescription Dermatological Drugs Sales by Company (2017-2022) & (K Units)
Table 89. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Company (2017-2022)
Table 90. Asia Pacific Prescription Dermatological Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 91. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Company (2017-2022)
Table 92. Asia Pacific Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
Table 93. Asia Pacific Prescription Dermatological Drugs Sales by Type (2023-2028) & (K Units)
Table 94. Asia Pacific Prescription Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 95. Asia Pacific Prescription Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 96. Asia Pacific Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Asia Pacific Prescription Dermatological Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Asia Pacific Prescription Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 99. Asia Pacific Prescription Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 100. Asia Pacific Prescription Dermatological Drugs Sales by Region (2017-2022) & (K Units)
Table 101. Asia Pacific Prescription Dermatological Drugs Sales by Region (2023-2028) & (K Units)
Table 102. Asia Pacific Prescription Dermatological Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 103. Asia Pacific Prescription Dermatological Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 104. Latin America Prescription Dermatological Drugs Sales by Company (2017-2022) & (K Units)
Table 105. Latin America Prescription Dermatological Drugs Sales Market Share by Company (2017-2022)
Table 106. Latin America Prescription Dermatological Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 107. Latin America Prescription Dermatological Drugs Revenue Market Share by Company (2017-2022)
Table 108. Latin America Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
Table 109. Latin America Prescription Dermatological Drugs Sales by Type (2023-2028) & (K Units)
Table 110. Latin America Prescription Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 111. Latin America Prescription Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 112. Latin America Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
Table 113. Latin America Prescription Dermatological Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Latin America Prescription Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 115. Latin America Prescription Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 116. Latin America Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)
Table 117. Latin America Prescription Dermatological Drugs Sales by Country (2023-2028) & (K Units)
Table 118. Latin America Prescription Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 119. Latin America Prescription Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 120. Middle East and Africa Prescription Dermatological Drugs Sales by Company (2017-2022) & (K Units)
Table 121. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Company (2017-2022)
Table 122. Middle East and Africa Prescription Dermatological Drugs Revenue by Company (2017-2022) & (US$ Million)
Table 123. Middle East and Africa Prescription Dermatological Drugs Revenue Market Share by Company (2017-2022)
Table 124. Middle East and Africa Prescription Dermatological Drugs Sales by Type (2017-2022) & (K Units)
Table 125. Middle East and Africa Prescription Dermatological Drugs Sales by Type (2023-2028) & (K Units)
Table 126. Middle East and Africa Prescription Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 127. Middle East and Africa Prescription Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 128. Middle East and Africa Prescription Dermatological Drugs Sales by Application (2017-2022) & (K Units)
Table 129. Middle East and Africa Prescription Dermatological Drugs Sales by Application (2023-2028) & (K Units)
Table 130. Middle East and Africa Prescription Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 131. Middle East and Africa Prescription Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 132. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2017-2022) & (K Units)
Table 133. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2023-2028) & (K Units)
Table 134. Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 135. Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 136. Johnson & Johnson Corporation Information
Table 137. Johnson & Johnson Description and Overview
Table 138. Johnson & Johnson Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Units) and Gross Margin (2017-2022)
Table 139. Johnson & Johnson Prescription Dermatological Drugs Product and Services
Table 140. Johnson & Johnson Prescription Dermatological Drugs SWOT Analysis
Table 141. Johnson & Johnson Recent Developments
Table 142. Merck Corporation Information
Table 143. Merck Description and Overview
Table 144. Merck Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Units) and Gross Margin (2017-2022)
Table 145. Merck Prescription Dermatological Drugs Product and Services
Table 146. Merck Prescription Dermatological Drugs SWOT Analysis
Table 147. Merck Recent Developments
Table 148. LEO Pharma Corporation Information
Table 149. LEO Pharma Description and Overview
Table 150. LEO Pharma Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Units) and Gross Margin (2017-2022)
Table 151. LEO Pharma Prescription Dermatological Drugs Product and Services
Table 152. LEO Pharma Prescription Dermatological Drugs SWOT Analysis
Table 153. LEO Pharma Recent Developments
Table 154. Mylan Pharmaceuticals Corporation Information
Table 155. Mylan Pharmaceuticals Description and Overview
Table 156. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Units) and Gross Margin (2017-2022)
Table 157. Mylan Pharmaceuticals Prescription Dermatological Drugs Product and Services
Table 158. Mylan Pharmaceuticals Prescription Dermatological Drugs SWOT Analysis
Table 159. Mylan Pharmaceuticals Recent Developments
Table 160. Pfizer Corporation Information
Table 161. Pfizer Description and Overview
Table 162. Pfizer Prescription Dermatological Drugs Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Units) and Gross Margin (2017-2022)
Table 163. Pfizer Prescription Dermatological Drugs Product and Services
Table 164. Pfizer Prescription Dermatological Drugs SWOT Analysis
Table 165. Pfizer Rece

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs